AFP |
Blood donation collectors thrown out of Israeli parliament
Reuters JERUSALEM (Reuters) – The speaker of Israel’s parliament ordered a blood-collection crew to leave the legislature’s premises on Wednesday after it turned down an offer of a blood donation from an Ethiopian-born lawmaker. Knesset member Pnina … MDA Accuses Ethiopian MK of Provocation over BloodArutz Sheva Magen David Adom Won’t Let Ethiopian Jewish Member Of Knesset Donate BloodFailedMessiah.com |
Targeted antibody, immune checkpoint blocker rein in follicular lymphoma – Medical Xpress
|
Targeted antibody, immune checkpoint blocker rein in follicular lymphoma
Medical Xpress “The combination of the established antibody drug rituximab with the experimental drug pidilizumab so far also has a remarkably mild side effect profile,” Neelapu said. Of 29 study participants at a median follow-up of 15.4 months, 19 (66 percent) had … |
Researchers Identify a New Way to Predict the Prognosis for Heart Failure Patients – Newswise (press release)
Irish Medical Times |
Researchers Identify a New Way to Predict the Prognosis for Heart Failure Patients
Newswise (press release) Newswise — Johns Hopkins researchers have identified a new way to predict which heart failure patients are likely to see their condition get worse and which ones have a better prognosis. Their study is one of the first to show that energy metabolism … New findings advance the opportunities for a ‘pacemaker in a bottle’Irish Medical Times |
Idelalisib With Rituximab Boosts Survival in Relapsed CLL – Medscape
|
Idelalisib With Rituximab Boosts Survival in Relapsed CLL
Medscape In a phase 3 trial, known as Study 116, the investigational agent idelalisib (under development by Gilead), when added to rituximab (Rituxan), improved outcomes in patients with relapsed CLL. “Idelalisib is a targeted, highly selective, orally … Idelalisib plus rituximab extended survival in previously treated CLLHealio Idelalisib/Rituximab Combo Improves Survival in Late-Stage CLLCancer Network Gilead’s Pipeline EncouragesYahoo News |
Roche, Prothena Enter Into Worldwide Collaboration to Co-Develop Antibodies … – Benzinga
|
Roche, Prothena Enter Into Worldwide Collaboration to Co-Develop Antibodies …
Benzinga Roche (OTC: RHHBY) and Prothena Corporation plc (Nasdaq: PRTA), announced today that they have entered into a worldwide collaboration to develop and commercialize antibodies that target alpha-synuclein, including PRX002, Prothena’s monoclonal … Roche and Prothena to Devlop Antibodies for Parkinson’s DiseasePharmaceutical Processing Roche and Prothena Enter Into Worldwide Collaboration to Co-Develop and Co …MarketWatch Roche, Prothena ink potential $600 million deal for Parkinson’s diseaseSan Francisco Business Times (blog) RTT News –Seeking Alpha all 10 news articles » |
MDA Accuses Ethiopian MK of Provocation over Blood – Arutz Sheva
MDA Accuses Ethiopian MK of Provocation over BloodArutz ShevaKnesset Speaker MK Yuli Edelstein (Likud-Beytenu) expelled a Magen David Adom (MDA) team from the Knesset after it allegedly refused to take a blood donation from MK Pnina Tamano-Shata (Yesh …
Acute kidney injury worsens CV, renal outcomes in MI – Healio
Acute kidney injury worsens CV, renal outcomes in MIHealioPatients with MI who develop acute kidney injury are at increased risk for major adverse cardiac and renal events than those with kidney injury or MI alone, according to recent study findings. T…
Kidney Transplantation Global Clinical Trials Review, H2, 2013 – SBWire (press release)
|
Kidney Transplantation Global Clinical Trials Review, H2, 2013
SBWire (press release) Albany, NY — (SBWIRE) — 12/11/2013 — Clinical trial report, Kidney Transplantation Global Clinical Trials Review, H2, 2013″ provides data on the Kidney Transplantation clinical trial scenario. This report provides elemental information and data … |
Study identifies new way to predict prognosis for heart failure patients – Medical Xpress
Study identifies new way to predict prognosis for heart failure patientsMedical XpressJohns Hopkins researchers have identified a new way to predict which heart failure patients are likely to see their condition get worse and which ones have a better p…
RAA Inhibitors Tied to Longer Survival With Chronic Kidney Disease – Medscape
MedscapeRAA Inhibitors Tied to Longer Survival With Chronic Kidney DiseaseMedscapeNEW YORK (Reuters Health) Dec 10 – Patients with chronic kidney disease (CKD) who are taking angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor bloc…